DICOM Structured Reporting and Cancer Clinical Trials Results
Open Access
- 1 January 2007
- journal article
- Published by SAGE Publications in Cancer Informatics
- Vol. 4, CIN.S37032-56
Abstract
The use of biomarkers derived from radiological images as surrogate end-points in therapeutic cancer clinical trials is well established. DICOM is the ubiquitous standard for the interchange of images for both clinical use as well as research. It also has capabilities for the exchange of image-related information, including categorical and quantitative information derived from images. The use of DICOM Structured Reporting for the encoding and interchange of clinical trial results in a standard manner is reviewed.Keywords
This publication has 9 references indexed in Scilit:
- Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer ScreeningNew England Journal of Medicine, 2005
- Lung Image Database Consortium: Developing a Resource for the Medical Imaging Research CommunityRadiology, 2004
- End Points and United States Food and Drug Administration Approval of Oncology DrugsJournal of Clinical Oncology, 2003
- The evolution of Protégé: an environment for knowledge-based systems developmentInternational Journal of Human-Computer Studies, 2003
- Automatic Structuring of Radiology Reports: Harbinger of a Second Information Revolution in RadiologyRadiology, 2002
- Radiology ReportsAmerican Journal of Roentgenology, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Desiderata for Controlled Medical Vocabularies in the Twenty-First CenturyMethods of Information in Medicine, 1998
- Documenting the information content of images.1997